Overview

A Trial of Norethisterone Acetate and Expectant Management in Treatment of Simple Ovarian Cysts

Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
0
Participant gender:
Female
Summary
To compare the effectiveness of (norethisterone acetate) in the treatment of spontaneously occurring simple ovarian cyst detected by ultrasonography compared with expectant management.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Assiut University
Treatments:
Norethindrone
Norethindrone Acetate
Criteria
Inclusion Criteria:

1. women at age 24-49 years old

2. women with simple cyst.( with none of the following: solid parts, papillary
formations, peritoneal masses, intraabdominal lymph node enlargement or ascites )
.(13)

3. from 5 to10cm in diameter.

4. functioning cyst.( defined as largest dimension between 2-8 cm in diameter,
unilateral, uniloculated, thin-walled, anechogenic and has distal acoustic enhancement
)

Exclusion Criteria:

1. premenarche

2. postmenopause

3. current user of Norethisterone acetate.

4. those having contraindication from Norethisterone use.

5. gynecologic malignancy